Acerus Pharmaceuticals Corp. engages in the development, manufacture, production, marketing, and distribution of women's and men's health products. It focuses on therapeutics for urology, hormone replacement therapy, and female dysfunction. Its products include Estrace, Natesto, Gynoflor, and Tefina. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus, and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada.